Today, Brokerages Set Herbalife Ltd. (HLF) Target Price at $67.43

Today, Brokerages Set Herbalife Ltd. (HLF) Target Price at $67.43
Herbalife Ltd. (NYSE:HLF) has earned an average rating of “Hold” from the six research firms that are covering the firm. Five investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $67.43.

A number of research analysts have issued reports on the company. Zacks Investment Research cut Herbalife from a “buy” rating to a “hold” rating in a report on Friday, November 4th. SunTrust Banks Inc. reissued a “neutral” rating and set a $66.00 price objective on shares of Herbalife in a report on Friday, August 5th. Pivotal Research reissued a “buy” rating and set a $90.00 price objective on shares of Herbalife in a report on Wednesday, October 26th. Finally, TheStreet cut Herbalife from a “buy” rating to a “hold” rating in a report on Tuesday, August 9th.

Herbalife (NYSE:HLF) opened at 50.87 on Tuesday. The stock has a 50 day moving average of $57.95 and a 200-day moving average of $60.98. The firm has a market cap of $4.73 billion, a price-to-earnings ratio of 17.86 and a beta of 1.87. Herbalife has a 52-week low of $42.26 and a 52-week high of $72.22.

Herbalife (NYSE:HLF) last issued its quarterly earnings data on Tuesday, November 1st. The company reported $1.21 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.09 by $0.12. The company earned $1.12 billion during the quarter, compared to analysts’ expectations of $18.70 million. Herbalife had a return on equity of 1,018.52% and a net margin of 5.40%. The business’s revenue was up 1.7% on a year-over-year basis. During the same period last year, the business earned $1.28 earnings per share. On average, analysts expect that Herbalife will post $4.85 EPS for the current year.

In other news, major shareholder Carl C. Icahn acquired 1,056,069 shares of the company’s stock in a transaction on Tuesday, November 8th. The stock was purchased at an average cost of $55.05 per share, with a total value of $58,136,598.45. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, major shareholder Carl C. Icahn acquired 1,832,402 shares of the company’s stock in a transaction on Thursday, November 3rd. The shares were purchased at an average cost of $54.70 per share, with a total value of $100,232,389.40. The disclosure for this purchase can be found here. 4.91% of the stock is owned by corporate insiders.

Hedge funds have recently made changes to their positions in the company. BlueMountain Capital Management LLC boosted its stake in shares of Herbalife by 1.0% in the first quarter. BlueMountain Capital Management LLC now owns 483,067 shares of the company’s stock valued at $29,738,000 after buying an additional 4,579 shares in the last quarter. BNP Paribas Arbitrage SA boosted its stake in shares of Herbalife by 8.8% in the second quarter. BNP Paribas Arbitrage SA now owns 11,057 shares of the company’s stock valued at $647,000 after buying an additional 891 shares in the last quarter. William Blair Investment Management LLC boosted its stake in shares of Herbalife by 988.3% in the second quarter. William Blair Investment Management LLC now owns 1,644,193 shares of the company’s stock valued at $96,235,000 after buying an additional 1,493,113 shares in the last quarter. Acadian Asset Management LLC purchased a new stake in shares of Herbalife during the second quarter valued at $3,856,000. Finally, Vanguard Group Inc. boosted its stake in shares of Herbalife by 12.8% in the second quarter. Vanguard Group Inc. now owns 6,044,640 shares of the company’s stock valued at $353,792,000 after buying an additional 688,272 shares in the last quarter.

Related posts

Leave a Comment